Biography:
Prof. Tarek Aboul-Fadl has completed his PhD in Medicinal Chemistry from Assiut University, Egypt (1994) under the channel system and joint supervision scheme between Assiut University and Josai University/Japan. He performed his postdoctoral training as a postdoctoral research fellow and scientist of Pharmaceutical and Medicinal Chemistry at University of Vienna, Austria (1997- 1998), Friedrich-Alexander- Universität, Erlangen-Nürnberg, Germany (1999 and 2013) and University of Utah, USA (2001-2002 and 2004-2005). He has over 85 publications and 4 patents that have been cited over 2065 times, and his publication H-index is 23 (google_scholar), 21(Scopus). He was awarded ACDIMA Research Award for Best Scientific Research in Arab World, 2012.
Title : Tetrahydro-(2H)-1,3,5-thiadiazine-2-thione (THTT), A versatile carrier system for targeting cell cycle checkpoint pathways with potential anticancer activities
Title : Thiadiazine-2-thione derivatives as new carrier systems for isothiocyanates and dithiocarbamic acid with potential anticancer activities
Title : Prodrugs of non-steroidal anti-inflammatory drugs (NSAIDs) and Amino acid esters as novel non-cyclooxygenase inhibitors for colorectal cancer chemoprevention